Dysregulation of T-cell function in the elderly: Scientific basis and clinical implications

Drugs and Aging

Volumn 22, Issue 7, 2005, Pages 589-603

  Fulop, Tamas ^a   Larbi, Anis ^a   Wikby, Anders ^b   Mocchegiani, Eugenio ^c   Hirokawa, Katsuiku ^d   Pawelec, Graham ^e  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b JÖNKÖPING UNIVERSITY   (Sweden)

^c INRCA   (Italy)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; PRASTERONE; RECOMBINANT INTERLEUKIN 2; ZINC;

ADAPTIVE BEHAVIOR; ALZHEIMER DISEASE; CELL AGING; CELL FUNCTION; CELL INTERACTION; CELL SUBPOPULATION; CELLULAR IMMUNITY; CLINICAL TRIAL; HUMAN; IMMUNOMODULATION; INFLUENZA; INNATE IMMUNITY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 24044463890     PISSN: 1170229X     EISSN: 1170229X     Source Type: Journal    
DOI: 10.2165/00002512-200522070-00005     Document Type: Review

References (98)

1. Parker LC, Whyte MKB, Dower SK, et al. The expression and roles of toll-like receptors in the biology of the human neutrophil. J Leukoc Biol 2005; 77: 1-7
2. Gavazzi G, Krauze KH. Ageing and infection. Lancet Infect Dis 2002; 2: 659-66
3. Castle SC. Clinical relevance of age-related immune dysfuntion. Clin Infect Dis 2000; 31: 578-85
4. DeVeale B, Brummer T, Seroude L. Immunity and aging: the enemy within? Aging Cell 2004; 3: 195-208
5. Wick G, Jansen-Dürr P, Berger P, et al. Diseases of aging. Vaccine 2000; 18: 1567-83
6. Grubeck-Loebenstein B, Wick G. The aging of the immune system. Annu Rev Immunol 2002; 80: 248-90
7. Hirokawa K, Utsuyama M, Kasai M, et al. Understanding the mechanism of age-change of thymic function to promote T-cell differentiation. Immunol Lett 1994; 40: 269-77
8. + T cells provides new insights on immunodeficiency in aging. Blood 2000; 95: 2860-8
9. Hirokawa K, Utsuyama M. Combined grafting of bone marrow and thymus, and sequential multiple thymus grafting in various strains of mice: the effect on immune functions and life span. Mech Ageing Dev 1989; 49: 49-60
10. Mocchegiani E, Giacconi R, Cipriano C, et al. The variations during the circadian cycle of liver CD1d-unrestricted NK1.1+TCR gamma/delta+ cells lead to successful ageing: role of metallothionein/IL-6/gp130/PARP-1 interplay in very old mice. Exp Gerontol 2004; 39: 775-88
11. Pawelec G, Akbar A, Caruso C, et al. Is immunosenescence infectious? Trends Immunol 2004; 25: 406-10
12. Looney RJ, Falsey A, Campbell D, et al. Role of cytome-galovirus in the T cell changes seen in elderly individuals. Clin Immunol 1999; 90: 213-9
13. Appay V, Dunbar PR, Callan M, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8: 379-85
14. Effros RB, Boucher N, Porter V, et al. Decline in CD28- T cells in centenarians and in long-term cell cultures: a possible cause for both in vivo and vitro immunosenescence. Exp Gerontol 1994; 29: 601-9
15. Effros RB, Pawelec G. Replicative senescence of T lymphocytes: does the Hayflick limit lead to immune exhaustion? Immunol Today 1997; 18: 450-4
16. Franceschi C, Bonafé M, Valensin S, et al. Inflamm-aging: an evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244-54
17. Franceschi C, Bonafé M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 2000; 18: 1717-20
18. + T cells that reach replicative senescence after multiple rounds of antigen specific proliferation. Exp Gerontol 1999; 34: 633-44
19. + cultured T cell clones. Exp Gerontol 1996; 31: 655-68
20. Mocchegiani E, Malavolta M. NK and NKT cell functions in immunosenescence. Aging Cell 2004; 3: 177-84
21. Pawelec G. Immunosenescence impact in the young as well as the old. Mech Age Dev 1999; 108: 1-7
22. Hirokawa K. Immunity and aging. In: Pathy MSJ, editor. Principles and practice of geriatric medicine. 3rd ed. New York: John Wiley and Sons, 1998: 35-47
23. O'Mahony L, Holland J, Jackson J, et al. Quantitative intracellular cytokine measurement: age-related changes in proinflammatory cytokine production. Clin Exp Immunol 1998; 113: 213-9
24. Trzonkowski P, Mysliwska J, Szmit E, et al. Association between cytomegalovisrus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination: an impact of immunosenescence. Vaccine 2003; 21: 3826-36
25. Baggio G, Donazzan S, Monti D, et al. Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors. FASEB J 1998; 12: 433-7
26. Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999; 47: 639-46
27. Cohen HJ, Piper CS, Harris T. Markers of inflammation and coagulation predict decline in function and mortality in community dwelling elderly. J Am Geriatr Soc 2001; S1: A3-A10
28. Franceschi C, Bonafé M. Centenarians as a model for healthy aging. Biochem Soc Trans 2001; 31: 457-61
29. Bonafé M, Olivieri F, Cavallone L, et al. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 2001; 31: 2357-61
30. Murasko D, Gardner EM. Immunology of aging. In: Hazzard WR, Blass JP, Halter JB, et al, editors. Principles of geriatric medicine and gerontology. New York: McGraw-Hill, 2003: 35-52
31. Bromley SK, Burack WR, Johnson KG, et al. The immunological synapse. Annu Rev Immunol 2001; 19: 375-96
32. Plackett TP, Boehmer ED, Faunce DE, et al. Aging and innate immune cells. J Leukoc Biol 2004; 76: 291-9
33. Garcia GG, Miller RA. Age-dependent defects in TCR-triggered cytoskeletal rearrangement in CD4+ T cells. J Immunol 2002; 169: 5021-7
34. Fulop T, Larbi A, Douziech N, et al. Signal transduction and functional changes in neutrophils with aging. Aging Cell 2004; 3: 217-26
35. Nel AE, Slaughter N. T-cell activation through the antigen receptor: Part 2: role of signaling cascades in T-cell differentiation, anergy, immune senescence, and development of immunotherapy. J Allergy Clin Immunol 2002; 109: 901-15
36. Rudd CE, Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat Rev Immunol 2003; 3: 544-56
37. Laude AJ, Prior IA. Plasma membrane microdomains: organization, function and trafficking. Mol Membr Biol 2004; 21: 193-205
38. Taner SB, Onfelt B, Pirinen NJ, et al. Control of immune responses by trafficking cell surface proteins, vesicles and lipid rafts to and from the immunological synapse. Traffic 2004; 5: 651-61
39. Pawelec G, Hirokawa K, Fulop T. T cell signalling with aging. Mech Ageing Dev 2001; 122: 1613-37
40. Larbi A, Douziech N, Dupuis G, et al. Age-associated alterations in the recruitment of signal transduction proteins to lipid rafts in human T lymphocytes. J Leukoc Biol 2004; 75: 373-81
41. Lesourd BM. Immune response during disease and recovery in the elderly. Proc Nutr Soc 1999; 58: 85-98
42. Lesourd BM. Nutrition and immunity in the elderly: modification of immune responses with nutritional treatments. Am J Clin Nutr 1997; 66: 478S-84S
43. Corman LC. The relationship between nutrition, infection and immunity. Med Clin North Am 1985; 69: 519-31
44. Sullivan DH, Sun S, Wals RC. Protein-energy malnutrition among elderly hospitalized patients: a prospective study. JAMA 1999; 281: 2013-9
45. Chandra RK. The relation between immunology, nutrition and disease in the elderly people. Age Ageing 1990; 19: S25-31
46. High KP. Nutritional strategies to boost immunity and prevent infections in the elderly individuals. Clin Infect Dis 2001; 33: 1892-900
47. Mocchegiani E, Muzzioli M, Giacconi R. Zinc, metallothioneins, immune responses, survival and ageing. Biogerontology 2000; 1: 133-43
48. Mocchegiani E, Giacconi R, Muzzioli M, et al. Zinc, infections and immunosenescence. Mech Ageing Dev 2000; 121: 21-35
49. Bruunsgaard H, Skinboj P, Qvist J, et al. Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. J Infect Dis 1999; 180: 551-4
50. Krabbe KS, Bruunsgaard H, Hanson CM, et al. Aging is associated with a prolonged fever response in human endotoxemia. Clin Diagn Lab Immunol 2001; 8: 333-8
51. Arlt W, Hewison M. Hormones and immune function: implications of aging. Aging Cell 2004; 3: 209-16
52. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298-300
53. Burns EA, Goodwin JS. Immunodeficiency and aging. Drugs Aging 1997; 11: 374-97
54. Pahlavani MA, Harris MD. Effect of in vitro generation of oxygen free radicals on T cell function in young and old rats. Free Radic Biol Med 1998; 25: 903-13
55. Wikby A, Johansson B, Ferguson F, et al. Age-related changes in immune parameters in a very old population of Swedish people: a longitudinal study. Exp Gerontol 1994; 29: 531-41
56. Saurwein-Teissl M, Lung TL, Marx F, et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002; 168: 5893-9
57. Goronzy JJ, Fulbright JW, Crowson CS, et al. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 2001; 75: 12182-7
58. Nilsson B-O, Ernerudh J, Johansson B, et al. Morbidity does not influence the T-cell immune risk phenotype in the elderly: findings in the Swedish NONA Immune Study using sample selection protocols. Mech Ageing Dev 2003; 124: 469-76
59. Ferguson FG, Wikby A, Maxson P, et al. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and non survivors. J Gerontol A Biol Sci Med Sci 1995; 50: B378-82
60. Olsson J, Wikby A, Johannson B, et al. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000; 121: 187-201
61. Yoshikawa TT. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis 2000; 30: 931-3
62. Mocchegiani E, Muzzioli M, Giacconi R, et al. Metallothioneins/PARP-1/IL- 6 interplay on natural killer cell activity in elderly. Parallelism with nonagenarians and old infected humans: effect of zinc supply. Mech Ageing Dev 2003; 124: 459-68
63. Mocchegiani E, Muzzioli M. Therapeutic application of zinc in human immunodeficiency virus against opportunistic infections. J Nutr 2000; 130: 1424S-31S
64. Holt SE, Shay JW, Wright WE. Refining the telomere-telomerase hypothesis of aging and cancer. Nat Biotechnol 1996; 14: 836-9
65. Balducci L. Anemia, cancer, and aging. Cancer Control 2003; 10: 478-86
66. Bonafé M, Valensin S, Gianni W, et al. The unexpected contribution of immunosenescence to the leveling off of cancer incidence and mortality in the oldest old. Crit Rev Oncol Hematol 2001; 39: 227-33
67. Fraumeni Jr JF, Hoover R. Immunosurveillance and cancer: epidemiologic observations. Natl Cancer Inst Monogr 1977; 47: 121-6
68. Shankaran V, Ikeda H, Bruce AT, et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001; 410: 1107-11
69. Panossian L, Porter VR, Valenzuela HF, et al. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging 2003; 24: 77-84
70. Zhang L, Conejo-Garcia JR, Katsaros D, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003; 348: 203-13
71. Blasko I, Marx F, Steiner E, et al. TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs. FASEB J 1999; 13: 63-8
72. Barger SW, Hörster D, Furukawa K, et al. Tumor necrosis factors alpha and beta protect neurons against amyloid beta peptide toxicity: evidence for involvement of a kappa-B binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci U S A 1995; 92: 9328-32
73. Blasko I, Schmitt TL, Steiner I, et al. Tumor necrosis factor alpha augments amyloid beta protein (25-35) induced apoptosis in human cells. Neurosci Lett 1997; 238: 17-20
74. Pasinetti GM, Aisen PS. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer disease brain. Neuroscience 1998; 87: 319-24
75. Jonasson L, Tompa A, Wikby A. Expansion of peripheral CD8+ T cells in patients with coronary artery disease: relation to cytomegalovirus infection. J Intern Med 2003; 254: 472-8
76. Wick G, Knoflach M, Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 2004; 22: 361-403
77. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004; 292: 344-50
78. Wick G, Perschinka H, Millonig G. Atherosclerosis as an autoimmune disease: an update. Trends Immunol 2001; 22: 665-9
79. Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-41
80. Hansson GK, Seifert PS, Olsson G, et al. Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 1991; 11: 745-50
81. Wick G, Scett G, Amberger A, et al. Is athersoclerosis an immunologically mediated disease? Immunol Today 1995; 16: 27-33
82. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74
83. Goavert TM, Thijs CT, Masurel N, et al. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA 1999; 272: 1661-5
84. Fulop T, Wagner JR, Khalil A, et al. Relationship between response to influenza vaccination and the nutritional status in institutionalized elderly subjects. J Gerontol 1999; 54A: M59-64
85. Nichol KL, Wuorenma I, von Sternberg T. Benefits of influenza vaccination for low-, intermediate- and high-risk senior citizens. Arch Intern Med 1998; 158: 1769-76
86. Guebre-Xabier M, Hammond SA, Ellingsworth LR. Immunostimulant patch enhances immune responses to influenza virus vaccine in aged mice. J Virol 2004; 78: 7610-8
87. Langkamp-Henken B, Bender BS, Gardner EM, et al. Nutritional formula enhanced immune function and reduced days of symptoms of upper respiratory tract infection in seniors. J Am Geriatr Soc 2004; 52: 3-12
88. Utsuyama M, Ichikawa M, Konno-Shirakawa A, et al. Retardation of the age-associated decline of immune functions in aging rats under dietary restriction and daily physical exercise. Mech Ageing Dev 1996; 91: 219-28
89. Autran B, Carcelain G, Combadiere B, et al. Therapeutic vaccines for chronic infections. Science 2004; 305: 205-8
90. Franceschi C, Valensin S, Lescai F, et al. Neuroinflammation and the genetics of Alzheimer's disease: the search for a pro-inflammatory phenotype. Aging (Milano) 2001; 13: 163-70
91. Kovacs EJ, Plackett TP, Witte PL. Estrogen replacement, aging, and cell-mediated immunity after injury. J Leukoc Biol 2004; 76: 36-41
92. Anversa P, Leri A, Kajstura J, et al. Myocyte growth and cardiac repair. Mol Cell Cardiol 2002; 34: 91-105
93. Bagnara GP, Bonsi L, Strippoli P, et al. Hemopoiesis in healthy old people and centenarians: well-maintained responsiveness of CD34+ cells to hemopoietic growth factors and remodeling of cytokine network. J Gerontol 2000; 55: B67-70
94. Aspinall R, Andrew D, Pido-Lopez J. Age-associated changes in thymopoiesis. Springer Semin Immunopathol 2002; 24: 87-101
95. Nickoloff BJ, Nestle FO. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 2004; 113: 1664-75
96. Blattman JN, Greenberg PD. Cancer immunotherapy: a treatment for the masses. Science 2004; 305: 200-5
97. Sutmuller RP, van Duivenvoorde LM, van Elsas A, et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001; 194: 823-32
98. Mocchegiani E, Straub RH. Possible new anti-aging strategies related to neuroendocrine-immune interactions. In: Straub RH, Mocchegiani E, editors. The neuroendocrine immune network in aging. Neuroimmune biology. Vol 4. Amsterdam: Elsevier, 2004: 399-409